These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 19636423)
1. Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors. Egloff AM; Grandis JR J Oncol; 2009; 2009():896407. PubMed ID: 19636423 [TBL] [Abstract][Full Text] [Related]
2. Overview of Current Treatment Options and Investigational Targeted Therapies for Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Zibelman M; Mehra R Am J Clin Oncol; 2016 Aug; 39(4):396-406. PubMed ID: 26967327 [TBL] [Abstract][Full Text] [Related]
3. New approaches to EGFR inhibition for locally advanced or metastatic squamous cell carcinoma of the head and neck (SCCHN). Agulnik M Med Oncol; 2012 Dec; 29(4):2481-91. PubMed ID: 22252310 [TBL] [Abstract][Full Text] [Related]
4. Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck. Xi S; Zhang Q; Dyer KF; Lerner EC; Smithgall TE; Gooding WE; Kamens J; Grandis JR J Biol Chem; 2003 Aug; 278(34):31574-83. PubMed ID: 12771142 [TBL] [Abstract][Full Text] [Related]
5. Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck. Campbell NP; Hensing TA; Bhayani MK; Shaikh AY; Brockstein BE Expert Rev Anticancer Ther; 2016 Aug; 16(8):847-58. PubMed ID: 27400139 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor receptor (EGFR)-targeted therapy in squamous cell carcinoma of the head and neck (SCCHN). Price KA; Cohen EE Oral Oncol; 2015 May; 51(5):399-408. PubMed ID: 25725588 [TBL] [Abstract][Full Text] [Related]
7. Anti-EGFR therapies: clinical experience in colorectal, lung, and head and neck cancers. Vokes EE; Chu E Oncology (Williston Park); 2006 Apr; 20(5 Suppl 2):15-25. PubMed ID: 16736979 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells. Rubin Grandis J; Chakraborty A; Melhem MF; Zeng Q; Tweardy DJ Oncogene; 1997 Jul; 15(4):409-16. PubMed ID: 9242377 [TBL] [Abstract][Full Text] [Related]
9. Current Aspects and Future Considerations of EGFR Inhibition in Locally Advanced and Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck. Patel B; Saba NF Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298761 [TBL] [Abstract][Full Text] [Related]
10. Antiepidermal growth factor receptor therapy in squamous cell carcinoma of the head and neck. Shaib W; Kono S; Saba N J Oncol; 2012; 2012():521215. PubMed ID: 22778735 [TBL] [Abstract][Full Text] [Related]
11. EGFR-targeted therapies in the post-genomic era. Xu MJ; Johnson DE; Grandis JR Cancer Metastasis Rev; 2017 Sep; 36(3):463-473. PubMed ID: 28866730 [TBL] [Abstract][Full Text] [Related]
12. Advances in molecular diagnostics and therapeutics in head and neck cancer. Chai RL; Grandis JR Curr Treat Options Oncol; 2006 Jan; 7(1):3-11. PubMed ID: 16343364 [TBL] [Abstract][Full Text] [Related]
13. Targeted therapy in head and neck cancer: state of the art 2007 and review of clinical applications. Langer CJ Cancer; 2008 Jun; 112(12):2635-45. PubMed ID: 18442098 [TBL] [Abstract][Full Text] [Related]
14. Biology and patterns of response to EGFR-inhibition in squamous cell cancers of the lung and head & neck. Juergens RA; Bratman SV; Tsao MS; Laurie SA; Sara Kuruvilla M; Razak AR; Hansen AR Cancer Treat Rev; 2017 Mar; 54():43-57. PubMed ID: 28192747 [TBL] [Abstract][Full Text] [Related]
15. Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck. Hoellein A; Pickhard A; von Keitz F; Schoeffmann S; Piontek G; Rudelius M; Baumgart A; Wagenpfeil S; Peschel C; Dechow T; Bier H; Keller U Oncotarget; 2011 Aug; 2(8):599-609. PubMed ID: 21865609 [TBL] [Abstract][Full Text] [Related]
16. Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck. Reuter CW; Morgan MA; Eckardt A Br J Cancer; 2007 Feb; 96(3):408-16. PubMed ID: 17224925 [TBL] [Abstract][Full Text] [Related]
17. Early investigational drugs that target epidermal growth factor receptors for the treatment of head and neck cancer. Ugurluer G; Ozsahin M Expert Opin Investig Drugs; 2014 Dec; 23(12):1637-54. PubMed ID: 25134724 [TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor directed therapy in head and neck cancer. Choong NW; Cohen EE Crit Rev Oncol Hematol; 2006 Jan; 57(1):25-43. PubMed ID: 16207530 [TBL] [Abstract][Full Text] [Related]